Acura Pharmaceuticals (STU:HD4B) Total Assets: €0.76 Mil (As of Dec. 2021)


STU:HD4B Acura Pharmaceuticals Inc STU:HD4B
16 GF Score
Price €0.20
View Full Analysis

What is Acura Pharmaceuticals Total Assets?

Acura Pharmaceuticals STU:HD4B 16 Total Assets is €0.76 Mil as of Dec. 2021. GuruFocus rates STU:HD4B with a GF Score™ of 16/100.

Acura Pharmaceuticals's Total Assets for the quarter that ended in Dec. 2021 was €0.76 Mil.

Total Assets is connected with ROA %. Acura Pharmaceuticals's annualized ROA % for the quarter that ended in Dec. 2021 was 10.63%. Total Assets is also linked to Revenue through Asset Turnover. Acura Pharmaceuticals's Asset Turnover for the quarter that ended in Dec. 2021 was 0.03.

Acura Pharmaceuticals  (STU:HD4B) Total Assets Explanation

Total Assets is connected with ROA %.

Acura Pharmaceuticals's annualized ROA % for the quarter that ended in Dec. 2021 is

ROA %=Net Income (Q: Dec. 2021 )/( (Total Assets (Q: Sep. 2021 )+Total Assets (Q: Dec. 2021 ))/ count )
=0.104/( (1.195+0.761)/ 2 )
=0.104/0.978
=10.63 %

Note: The Net Income data used here is four times the quarterly (Dec. 2021) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Acura Pharmaceuticals's Asset Turnover for the quarter that ended in Dec. 2021 is

Asset Turnover
=Revenue (Q: Dec. 2021 )/( (Total Assets (Q: Sep. 2021 )+Total Assets (Q: Dec. 2021 ))/ count )
=0.032/( (1.195+0.761)/ 2 )
=0.032/0.978
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Acura Pharmaceuticals Total Assets Related Terms

Acura Pharmaceuticals Total Assets Historical Data

* Premium members only.

The historical data trend for Acura Pharmaceuticals's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acura Pharmaceuticals Total Assets Chart

Acura Pharmaceuticals Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.89 1.89 2.31 1.43 0.76

Acura Pharmaceuticals Quarterly Data
Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.43 1.61 1.57 1.20 0.76
STU:HD4B
16GF Score
Acura Pharmaceuticals Inc STU:HD4B
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Acura Pharmaceuticals Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Acura Pharmaceuticals's Total Assets for the fiscal year that ended in Dec. 2021 is calculated as

Total Assets=Total Equity (A: Dec. 2021 )+Total Liabilities (A: Dec. 2021 )
=0.158+0.604
=0.76

Acura Pharmaceuticals's Total Assets for the quarter that ended in Dec. 2021 is calculated as

Total Assets=Total Equity (Q: Dec. 2021 )+Total Liabilities (Q: Dec. 2021 )
=0.158+0.604
=0.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of €0.76 Mil mean?
Acura Pharmaceuticals (STU:HD4B) has a Total Assets of €0.76 Mil as of Dec. 2021. The total amount of assets as recorded on a company's balance sheet. View historical data on Acura Pharmaceuticals and its competitors.
Is Acura Pharmaceuticals' Total Assets too high?
Acura Pharmaceuticals' current Total Assets is €0.76 Mil. Overall, Acura Pharmaceuticals has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Acura Pharmaceuticals' Total Assets compare to VFRM and THCT?
Acura Pharmaceuticals' Total Assets of €0.76 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Drug Manufacturers company?
A good Total Assets depends on the Drug Manufacturers industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Acura Pharmaceuticals and its competitors. Acura Pharmaceuticals's current Total Assets is €0.76 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acura Pharmaceuticals stock overvalued right now?
Acura Pharmaceuticals (STU:HD4B) has a current Total Assets of €0.76 Mil. The current Total Assets is €0.76 Mil. Acura Pharmaceuticals' overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Acura Pharmaceuticals (STU:HD4B), the current Total Assets is €0.76 Mil as of Dec. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Acura Pharmaceuticals Business Description

Address 616 N. North Court, Suite 120, Palatine, IL, USA, 60067
Acura Pharmaceuticals Inc is a drug delivery company engaged in the research, development and commercialization of technologies and products intended to address safe use of medications. It has discovered and developed three proprietary platform technologies which can be used to develop multiple products. Its Limitx Technology is being developed to minimize the risk of overdose, its Aversion Technology is intended to address methods of abuse associated with opioid analgesics while its Impede Technology is directed at minimizing the extraction and conversion of pseudoephedrine, or PSE, into methamphetamine. It operates in single segment being the research, development and commercialization of technologies and products intended to address safe use of medications.
16GF Score

Get the complete analysis for STU:HD4B

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.20
Price